Wake Forest Baptist Health Comprehensive Cancer Center

Winston-Salem, North Carolina 27157

2 studies enrolling now · 7 studies all time

What they study most

ET-MF, Glioblastoma, Glioblastoma Multiforme, Glioma, Gliosarcoma, Head and Neck Squamous Cell Carcinoma, Malignant Brain Tumor, Myelofibrosis, Myelofibrosis (PMF), Oral Mucositis, PV-MF, Pancreatic Cancer

Studies at this site

• Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120) — Recruiting now
• Study of Canakinumab in Patients With Myelofibrosis — Running, not enrolling
• Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias — Starting soon
• MIT-001 for Prevention of CCRT-Induced OM in HNSCC Patients — Running, not enrolling
• A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1 — Completed
• Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors — Completed
• Immunotherapy Study for Surgically Resected Pancreatic Cancer — Completed